# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882095-24-000028
Filing Date
2024-11-12
Accepted
2024-11-12 08:36:10
Documents
84
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | gild-20240930.htm iXBRL | 10-Q | 2450490
2 | SEVERANCE PLAN (AMENDED AND RESTATED) | gildq32024ex1041severancep.htm | EX-10.41 | 263845
3 | TRANSITION AND GENERAL RELEASE AGREEMENT (PARSEY) | gildq32024ex1051parseytran.htm | EX-10.51 | 125033
4 | CEO CERTIFICATION | gildq32024ex311ceocertific.htm | EX-31.1 | 8174
5 | CFO CERTIFICATION | gildq32024ex312cfocertific.htm | EX-31.2 | 7700
6 | SECTION 906 CERTIFICATIONS | gildq32024ex32section906ce.htm | EX-32 | 5814
12 | LOGO | image_0a.jpg | GRAPHIC | 5360
| Complete submission text file | 0000882095-24-000028.txt |  | 11664991

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | gild-20240930.xsd | EX-101.SCH | 59048
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | gild-20240930_cal.xml | EX-101.CAL | 104247
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | gild-20240930_def.xml | EX-101.DEF | 295338
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | gild-20240930_lab.xml | EX-101.LAB | 734268
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | gild-20240930_pre.xml | EX-101.PRE | 515248
87 | EXTRACTED XBRL INSTANCE DOCUMENT | gild-20240930_htm.xml | XML | 2251731

Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 241443773
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)